嗜酸乳杆菌和蒙脱石粉联合疗法对小儿轮状病毒肠炎炎症反应的影响

IF 2.5 4区 医学 Q3 ALLERGY
Qiong Wei, Li-Yao Song, Rui Rao, Hong-Wei Yang, Yao-Ping Wen, Li Lv, Li Wang
{"title":"嗜酸乳杆菌和蒙脱石粉联合疗法对小儿轮状病毒肠炎炎症反应的影响","authors":"Qiong Wei, Li-Yao Song, Rui Rao, Hong-Wei Yang, Yao-Ping Wen, Li Lv, Li Wang","doi":"10.1159/000542593","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study is to investigate the effects of the compound Lactobacillus acidophilus in combination with montmorillonite powder on the inflammatory response in children with rotavirus enteritis (RVE).</p><p><strong>Methods: </strong>A total of 94 children with RVE admitted to our hospital between June 2021 and April 2023 were selected and divided into two groups using a random digit table method. Each group consisted of 47 children. Both groups were administered standard symptomatic treatment upon admission. The control group was additionally administered montmorillonite powder, while the observation group was administered compound L. acidophilus tablets in addition to the treatment administered to the control group. Both the treatments were administered for a duration of five days. Parameters such as clinical efficacy, symptom relief time (diarrhea, vomiting, fever, dehydration), inflammatory response (C-reactive protein (CRP)), and adverse reactions (constipation, bloating, drowsiness, skin allergy, dry mouth) were compared between the two groups.</p><p><strong>Results: </strong>Post-treatment, the observation group exhibited a significantly higher total effective rate (95.74%) compared to the control group (78.72%). The symptom relief time for diarrhea ((2.23±0.48) days), vomiting ((1.38±0.25) days), fever ((1.91±0.68) days), and dehydration ((2.74±0.53) days) in the observation group were all significantly shorter than those in the control group ((3.42±0.71) days, (2.65±0.54) days, (2.76±0.84) days, and (4.60±0.89) days), respectively. The post-treatment CRP levels in the observation group were (5.26±1.32) mg/L, lower than those in the control group (7.45±1.58) mg/L, although this difference was not statistically significant. The incidence of adverse reactions was 14.89% in the observation group and 8.51% in the control group, with no significant difference between the groups.</p><p><strong>Conclusion: </strong>The combination of compound L. acidophilus and montmorillonite effectively shortens the symptom recovery time and improves inflammatory response in children with RVE, while maintaining a high safety profile.</p>","PeriodicalId":13652,"journal":{"name":"International Archives of Allergy and Immunology","volume":" ","pages":"1-13"},"PeriodicalIF":2.5000,"publicationDate":"2024-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Impact of Combined Therapy with Lactobacillus acidophilus and Montmorillonite Powder on the Inflammatory Response in Pediatric Rotavirus Enteritis.\",\"authors\":\"Qiong Wei, Li-Yao Song, Rui Rao, Hong-Wei Yang, Yao-Ping Wen, Li Lv, Li Wang\",\"doi\":\"10.1159/000542593\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>The aim of this study is to investigate the effects of the compound Lactobacillus acidophilus in combination with montmorillonite powder on the inflammatory response in children with rotavirus enteritis (RVE).</p><p><strong>Methods: </strong>A total of 94 children with RVE admitted to our hospital between June 2021 and April 2023 were selected and divided into two groups using a random digit table method. Each group consisted of 47 children. Both groups were administered standard symptomatic treatment upon admission. The control group was additionally administered montmorillonite powder, while the observation group was administered compound L. acidophilus tablets in addition to the treatment administered to the control group. Both the treatments were administered for a duration of five days. Parameters such as clinical efficacy, symptom relief time (diarrhea, vomiting, fever, dehydration), inflammatory response (C-reactive protein (CRP)), and adverse reactions (constipation, bloating, drowsiness, skin allergy, dry mouth) were compared between the two groups.</p><p><strong>Results: </strong>Post-treatment, the observation group exhibited a significantly higher total effective rate (95.74%) compared to the control group (78.72%). The symptom relief time for diarrhea ((2.23±0.48) days), vomiting ((1.38±0.25) days), fever ((1.91±0.68) days), and dehydration ((2.74±0.53) days) in the observation group were all significantly shorter than those in the control group ((3.42±0.71) days, (2.65±0.54) days, (2.76±0.84) days, and (4.60±0.89) days), respectively. The post-treatment CRP levels in the observation group were (5.26±1.32) mg/L, lower than those in the control group (7.45±1.58) mg/L, although this difference was not statistically significant. The incidence of adverse reactions was 14.89% in the observation group and 8.51% in the control group, with no significant difference between the groups.</p><p><strong>Conclusion: </strong>The combination of compound L. acidophilus and montmorillonite effectively shortens the symptom recovery time and improves inflammatory response in children with RVE, while maintaining a high safety profile.</p>\",\"PeriodicalId\":13652,\"journal\":{\"name\":\"International Archives of Allergy and Immunology\",\"volume\":\" \",\"pages\":\"1-13\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2024-11-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Archives of Allergy and Immunology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000542593\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ALLERGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Archives of Allergy and Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000542593","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

摘要

研究目的本研究旨在探讨复方嗜酸乳杆菌联合蒙脱石粉对轮状病毒肠炎(RVE)患儿炎症反应的影响:选取 2021 年 6 月至 2023 年 4 月期间我院收治的 94 名 RVE 患儿,采用随机数字表法将其分为两组。每组 47 名患儿。两组患儿入院时均接受标准的对症治疗。对照组额外服用蒙脱石粉,而观察组在对照组治疗的基础上服用复方嗜酸乳杆菌片剂。两种治疗均持续五天。比较两组的临床疗效、症状缓解时间(腹泻、呕吐、发热、脱水)、炎症反应(C反应蛋白(CRP))和不良反应(便秘、腹胀、嗜睡、皮肤过敏、口干)等参数:治疗后,观察组的总有效率(95.74%)明显高于对照组(78.72%)。观察组腹泻((2.23±0.48)天)、呕吐((1.38±0.25)天)、发热((1.91±0.68)天)、脱水((2.74±0.53)天)均明显短于对照组((3.42±0.71)天、(2.65±0.54)天、(2.76±0.84)天、(4.60±0.89)天)。观察组治疗后 CRP 水平为(5.26±1.32)毫克/升,低于对照组的(7.45±1.58)毫克/升,但差异无统计学意义。观察组不良反应发生率为 14.89%,对照组为 8.51%,组间差异无统计学意义:结论:复方嗜酸乳杆菌和蒙脱石的组合能有效缩短 RVE 患儿的症状恢复时间并改善炎症反应,同时保持较高的安全性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The Impact of Combined Therapy with Lactobacillus acidophilus and Montmorillonite Powder on the Inflammatory Response in Pediatric Rotavirus Enteritis.

Objective: The aim of this study is to investigate the effects of the compound Lactobacillus acidophilus in combination with montmorillonite powder on the inflammatory response in children with rotavirus enteritis (RVE).

Methods: A total of 94 children with RVE admitted to our hospital between June 2021 and April 2023 were selected and divided into two groups using a random digit table method. Each group consisted of 47 children. Both groups were administered standard symptomatic treatment upon admission. The control group was additionally administered montmorillonite powder, while the observation group was administered compound L. acidophilus tablets in addition to the treatment administered to the control group. Both the treatments were administered for a duration of five days. Parameters such as clinical efficacy, symptom relief time (diarrhea, vomiting, fever, dehydration), inflammatory response (C-reactive protein (CRP)), and adverse reactions (constipation, bloating, drowsiness, skin allergy, dry mouth) were compared between the two groups.

Results: Post-treatment, the observation group exhibited a significantly higher total effective rate (95.74%) compared to the control group (78.72%). The symptom relief time for diarrhea ((2.23±0.48) days), vomiting ((1.38±0.25) days), fever ((1.91±0.68) days), and dehydration ((2.74±0.53) days) in the observation group were all significantly shorter than those in the control group ((3.42±0.71) days, (2.65±0.54) days, (2.76±0.84) days, and (4.60±0.89) days), respectively. The post-treatment CRP levels in the observation group were (5.26±1.32) mg/L, lower than those in the control group (7.45±1.58) mg/L, although this difference was not statistically significant. The incidence of adverse reactions was 14.89% in the observation group and 8.51% in the control group, with no significant difference between the groups.

Conclusion: The combination of compound L. acidophilus and montmorillonite effectively shortens the symptom recovery time and improves inflammatory response in children with RVE, while maintaining a high safety profile.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.60
自引率
3.60%
发文量
105
审稿时长
2 months
期刊介绍: ''International Archives of Allergy and Immunology'' provides a forum for basic and clinical research in modern molecular and cellular allergology and immunology. Appearing monthly, the journal publishes original work in the fields of allergy, immunopathology, immunogenetics, immunopharmacology, immunoendocrinology, tumor immunology, mucosal immunity, transplantation and immunology of infectious and connective tissue diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信